SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-02-001376
Filing Date
2002-11-15
Accepted
2002-11-15 12:09:10
Documents
1
Group Members
BRIANNE GOLDSTEINJACLYN BELSONJOHNATHAN BELSONJOSHUA GOLDSTEINMARJORIE BELSONMAXINE BELSONTHE JEROME BELSON FOUNDATIONTOBY GOLDSTEIN

Document Format Files

Seq Description Document Type Size
1 doc1.txt SC 13D/A 40765
  Complete submission text file 0001144204-02-001376.txt   42867
Mailing Address BELSON ENTERPRISES, INC. 495 BROADWAY NEW YORK NY 10012
Business Address 495 BROADWAY 6TH FLOOR NEW YORK NY 10012 2129419500
BELSON JEROME (Filed by) CIK: 0000900685 (see all company filings)

 

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Subject) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-59693 | Film No.: 02829026
SIC: 2834 Pharmaceutical Preparations